Covex Pharma

Vinpocetine is a semi-synthetic derivative of vincamine, an alkaloid derived from the Vinca minor L. plant that has been used since the 1970s in Japan, Europe, Mexico, and Russia for the treatment of cerebrovascular and cognitive disorders. It can also be derived from tabersonine, the alkaloid extract of Voacanga seeds found mostly in West Africa. COVEX, S.A.’s Vinpocetine is obtained following the method in its Spanish Patent: ES 549.105. The starting material is Vincamine (derived from tabersonine, the alkaloid extract of Voacanga), manufactured at COVEX, S.A.’s own factory facilities in Colmenar Viejo (Madrid), Spain.

Vinburnine is a natural occurring product found in the plant Hunteria eburnea P., obtained by semi-synthesis from Vincamine, is a muscle oxygenator. Clinical trials show the effects of Vinburnine especially in oxygen release from red blood cells. Covex obtains Vinburnine through semi-synthetic process and distributes it worldwide as a high quality active ingredient. Its main application as a dietary supplement is to boost the metabolism of glucose inside the muscle. Every training athlete or person doing fitness exercises can obtain maximum muscle performance by taking vinburnine as a catalyst of physical work.

Vincamine is a natural occurring product found in the plant Vinca minor L., obtained by semi-synthesis. Used as a cerebral vasodilator for enhancing mental alertness, it increases blood flow to the brain and improves its oxygenation. The original use of this plant goes back to European traditional home remedy with a series of various applications. This herb is well known and widely used in popular medicine as an important component of herbal teas against nervousness in the elderly suffering from insomnia, anxiety and aggressiveness.